Evidence map›Paper›PMID 32676875›Full record

ReviewLa Radiologia medica2021

Multimodality imaging in chronic heart failure.

Ernesto Di Cesare, Scipione Carerj, Anna Palmisano, Maria Ludovica Carerj, Federica Catapano, Davide Vignale, Annamaria Di Cesare, Gianluca Milanese, Nicola Sverzellati, Marco Francone and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in La Radiologia medica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Ernesto Di CesareDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.ORCID http://orcid.org/0000-0002-1170-6266
Scipione CarerjDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Anna PalmisanoExperimental Imaging Center, Radiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Maria Ludovica CarerjDepartment of Biomedical Science, Dental, Morphological and Functional Images, University of Messina, Messina, Italy.
Federica CatapanoDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Davide VignaleExperimental Imaging Center, Radiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Annamaria Di CesareDepartment of Medical Sciences, Internal Medicine and Cardiorespiratory Section, University of Ferrara, Ferrara, Italy.
Gianluca MilaneseDepartment of Clinical Sciences, Section of Diagnostic Imaging, University Hospital of Parma, Parma, Italy.
Nicola SverzellatiDepartment of Clinical Sciences, Section of Diagnostic Imaging, University Hospital of Parma, Parma, Italy.
Marco FranconeDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.
Antonio EspositoExperimental Imaging Center, Radiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. esposito.antonio@hsr.it.
Vita-Salute San Raffaele University · ITSapienza University of Rome · ITUniversity of Messina · ITUniversity of Parma · ITUniversity of Ferrara · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of heart failure (HF) is approximately 1-2% of the adult population in developed countries, rising to  ≥ 10% among people over 70. The common symptoms of HF include shortness of breath, ankle swelling and fatigue, determined by a reduced cardiac output. Multimodality imaging is crucial to define HF etiology, determine prognosis and guiding tailored treatments. Echocardiography is the most widely used imaging modality and maintains a pivotal role in the initial diagnostic work-up and in the follow-up of HF patients. Cardiac magnetic resonance (CMR) may support the morpho-functional assessment provided by echocardiography when the acoustic window is limited or a gold standard evaluation is required. Furthermore, CMR is frequently used due to the unmatched capability to characterize myocardial structure. Coronary computed tomography angiography has become the non-invasive imaging of choice to diagnose or rule-out coronary artery disease, acquiring remarkable importance in the management of HF patients. Moreover, emerging capabilities of CT-based tissue characterization may be useful, especially when CMR is contraindicated. Finally, chest CT may contribute to precisely define the framework of HF patients, revealing new insight about cardiopulmonary pathophysiological interactions with potential high prognostic value.

Indexed as

Multimodal ImagingChronic DiseaseHeart FailureHumansPrognosisCardiac magnetic resonanceChronic heart failureComputed tomographyEchocardiographyHeart failure

Identifiers

PMID32676875
OpenAlexW3043644217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.